Vitamin K Antagonist
Showing 26 - 50 of 8,812
Observes Usage of Non-vitamin K Antagonist Oral Anticoagulants
Completed
- Atrial Fibrillation
- Non-vitamin K antagonist oral anticoagulant
-
Alcorcón, Madrid, Spain
- +44 more
Sep 2, 2021
Atrial Fibrillation Patients With Intermediate Stroke Risk Trial in Seoul (Anticoagulation group(Apixaban group))
Recruiting
- Atrial Fibrillation Patients With Intermediate Stroke Risk
- Anticoagulation group(Apixaban group)
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital Yonsei University
Aug 11, 2020
Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Anticoagulation Therapy (OAT), Existent Coronary or Valvular
Completed
- Atrial Fibrillation or Pulmonary Embolism
- +2 more
- Rivaroxaban or Marcumar
-
Coburg, Bavaria, Germany
- +2 more
Oct 21, 2020
Transcatheter Aortic Valve Replacement Trial in France (Vitamin K antagonist or direct oral anticoagulant treatment, Aspirin)
Recruiting
- Transcatheter Aortic Valve Replacement
- Vitamin K antagonist or direct oral anticoagulant treatment
- Aspirin
-
Montpellier cedex 2, France
- +5 more
Aug 4, 2021
Atrial Fibrillation Trial in Aalst (Rivaroxaban 10 MG Oral Tablet, MK-7 2000µg thrice weekly, Vitamin K Antagonist - Drug)
Completed
- Atrial Fibrillation
- Rivaroxaban 10 MG Oral Tablet
- +2 more
-
Aalst, BelgiumOLV Hospital
Nov 2, 2020
Deep Vein Thrombosis, Pulmonary Embolism Trial in Bologna (Vitamin K antagonist (Coumarin anticoagulants))
Completed
- Deep Vein Thrombosis
- Pulmonary Embolism
- Vitamin K antagonist (Coumarin anticoagulants)
-
Bologna, BO, ItalyDept. of Angiology & Blood Coagulation, University Hospital S. O
Mar 18, 2021
Registration of Idarucizumab for IntraCranial Hemorrhage
Completed
- Intracranial Hemorrhage
- Dabigatran Etexilate Oral Capsule [Pradaxa]
- +2 more
-
Bad Aibling, Germany
- +32 more
Apr 6, 2022
Late Vitamin K Deficiency-related Bleeding in Neonates:
Completed
- Late Vitamin K Deficiency-related Bleeding
- Konakion
-
Parma, ItalyPr Serafina Perrone
Feb 2, 2023
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
Completed
- Nonvalvular Atrial Fibrillation
- Rivaroxaban (Xarelto, BAY59-7939)
- Vitamin K antagonist (VKA)
-
Multiple Locations, WashingtonTruven Health MarketScan Commercial Claims and Medicare Suppleme
Aug 13, 2020
Diabetes, Type 2 Trial in Cairo (Vitamin K, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vitamin K
- Placebo
-
Cairo, EgyptKasr Al Aini Hospital
Jan 21, 2023
Overweight and Obesity, Cardiometabolic Risk Factors Trial in Guadalajara (Vitamin K2, Cornstarch)
Not yet recruiting
- Overweight and Obesity
- Cardiometabolic Risk Factors
- Vitamin K2
- Cornstarch
-
Guadalajara, Jalisco, MexicoUniversity of Guadalajara
Aug 8, 2023
Vitamin K Deficiency Trial in Aachen (Vitamin K supplement)
Completed
- Vitamin K Deficiency
- Vitamin K supplement
-
Aachen, GermanyRWTH Aachen University
Apr 29, 2022
Obesity, Vitamin D3 Deficiency Trial in Rio de Janeiro (Vitamin D3 + K2-MK7, Placebo, Vitamin D3)
Recruiting
- Obesity
- Vitamin D3 Deficiency
- Vitamin D3 + K2-MK7
- +2 more
-
Rio de Janeiro, BrazilRio de Janeiro State University
Jan 10, 2023
Antibiotic Side Effect Trial in Giza (Vitamin K)
Recruiting
- Antibiotic Side Effect
- Vitamin K
-
Giza, Egypt6-October Hospital
Feb 22, 2023
Vitamin K Status Trial in Seattle (Phase I, Buccal Swab Collection for DNA Isolation, Phase II, Vitamin K (Vitacost)
Recruiting
- Vitamin K Status
- Phase I, Buccal Swab Collection for DNA Isolation
- Phase II, Vitamin K (Vitacost) Supplementation
-
Seattle, WashingtonUniversity of Washington
Jun 9, 2022
Migraine Headache, Arterial Stiffness, Vitamin K Deficiency Trial in Beirut (Vitamin K2 or menaquinone-7, Placebo)
Not yet recruiting
- Migraine Headache
- +2 more
- Vitamin K2 or menaquinone-7
- Placebo
-
Beirut, LebanonLebanese American University Medical Center - Rizk Hospital
Jul 5, 2023
Bone Density, Bone Health, Fractures Trial in Boston (Vitamin D3 , Fish oil , Omega-3 fatty acids (fish oil))
Active, not recruiting
- Bone Density
- +2 more
- Vitamin D3 placebo
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 14, 2022
Coronary Artery Disease Trial in Odense (Vitamin K2 (Menaquinone-7))
Not yet recruiting
- Coronary Artery Disease
- Vitamin K2 (Menaquinone-7)
-
Odense, Odense C, DenmarkDepartment of Cardiology, Odense University Hospital
Aug 11, 2022
Vitamine K Antagonist (VKA) Treatment, International Normalized Ratio (INR) Measure at Home, Thromboembolic Pathology Trial in
Completed
- Vitamine K Antagonist (VKA) Treatment
- +2 more
- LabPad® point-of-care
-
Saint-Marcellin, FranceLaboratoire ORIADE NOVIALE
Apr 3, 2020
Prostheses and Implants, Stroke, Valve Heart Disease Trial in Salvador (Rivaroxaban 15 mg, Warfarin)
Terminated
- Prostheses and Implants
- +3 more
- Rivaroxaban 15 mg
- Warfarin
-
Salvador, Bahia, BrazilAndre Duraes
May 13, 2020
Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Vitamin K 2
- (no location specified)
Jul 4, 2023
Vitamin K Trial in Cairo (vitamin k)
Completed
- Vitamin K
- vitamin k
-
Cairo, EgyptNational Research Centre
Feb 12, 2022
Oxidative Stress, Inflammation Trial in Ede (Vitamin K2, Placebo)
Active, not recruiting
- Oxidative Stress
- Inflammation
- Vitamin K2
- Placebo
-
Ede, NetherlandsNIZO food research
Feb 2, 2023
Osteo Arthritis Knee Trial in Boston, Chapel Hill (Vitamin K, Placebo)
Not yet recruiting
- Osteo Arthritis Knee
- Vitamin K
- Placebo
-
Boston, Massachusetts
- +1 more
Aug 15, 2022
Covid19 Trial in Ottawa (drug, dietary supplement, other)
Suspended
- Covid19
- Vitamin D3 50,000 IU
- +4 more
-
Ottawa, Ontario, CanadaThe Centre for Health Innovation
Aug 8, 2022